Stage IA NSCLC VATS Outcomes with Intrapleural Hemocoagulase

442 stage IA non-small cell lung cancer patients were analyzed to evaluate the effects of intrapleural Hemocoagulase Bothrops atrox on postoperative coagulation and recovery. The dataset, authored by Yingding Ruan and last updated in April 2026, contains results from a retrospective study comparing 92 HBA-treated patients to 350 controls. Key findings include associations between HBA use and altered coagulation profiles, reduced complications, and shorter hospital stays.

Use Cases

• Modeling the association between intrapleural HBA and postoperative coagulation parameters like prothrombin time and fibrinogen levels.
• Predicting the risk of postoperative complications in stage IA NSCLC patients undergoing VATS.
• Analyzing the impact of pharmacological interventions on length of hospital stay after lung cancer surgery.

Strengths

• Study includes 442 patient records, providing a substantial cohort for analysis.
• Results are statistically adjusted using inverse probability of treatment weighting (IPTW) and multivariable analyses.
• Dataset is openly shared under a CC-BY-4.0 license, permitting reuse.

Limitations

• Row count and column-level documentation are unknown, limiting suitability assessment.
• Data is contained in a 26.8 KB DOCX file, suggesting a summary table rather than a raw patient-level dataset.
• The retrospective study design suggests observational data, which may limit causal inference.

Provenance

Source

figshare

Collection Method

Retrospective analysis of patient records.

Time Range

The study period is not specified in the provided metadata.

Freshness

Last updated 2026-04-10 05:29:37

Geography

Geographic coverage is not specified in the provided metadata.